In 2020, Gu et al. established a risk score model based on the expression of five genes (TSPAN7, MYBL2, GCSH, FBN2, and DDX39B) for the prognostic prediction of soft tissue sarcoma [46]. The gene discussed is GCSH; the disease is soft tissue sarcoma.